Kyong Hoon Suh

Title: Kyong Hoon Suh: Innovator in Antibody Development

Introduction

Kyong Hoon Suh is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 3 patents to his name, Suh's work focuses on enhancing diagnostic tools and treatments for various health conditions.

Latest Patents

One of Suh's latest patents is related to the thioredoxin 1 epitope, encoding nucleic acid, and methods of binding a monoclonal antibody. This invention pertains to an epitope of the thioredoxin-1 (Trx1) antigen, which can be utilized to develop improved antibodies that enhance binding affinity. The improved antibody is particularly effective in breast cancer diagnosis, offering high sensitivity and specificity compared to conventional methods.

Another significant patent involves a human antibody specifically binding to acne bacteria using phage display technology. This invention includes a human antibody that targets acne-inducing bacteria, along with its applications in cosmetic and pharmaceutical compositions.

Career Highlights

Kyong Hoon Suh is currently associated with E&S Healthcare Co., Ltd., where he continues to innovate in the field of healthcare. His work has the potential to significantly impact the diagnosis and treatment of diseases, particularly in oncology and dermatology.

Collaborations

Suh collaborates with notable colleagues, including Jong Hwan Jung and Ki Se Lee, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking advancements in their respective fields.

Conclusion

Kyong Hoon Suh is a prominent inventor whose work in antibody development is paving the way for improved diagnostic and therapeutic solutions. His innovative patents reflect a commitment to advancing healthcare technology and improving patient outcomes.